Literature DB >> 36229556

EAES rapid guideline: updated systematic review, network meta-analysis, CINeMA and GRADE assessment, and evidence-informed European recommendations on the management of common bile duct stones.

Luigi Boni1, Bright Huo2, Laura Alberici3, Claudio Ricci3,4, Sofia Tsokani5, Dimitris Mavridis5,6, Yasser Sami Amer7,8,9,10, Alexandros Andreou11, Thomas Berriman12, Gianfranco Donatelli13,14, Nauzer Forbes15,16, Stylianos Kapiris17, Cüneyt Kayaalp18, Leena Kylänpää19, Pablo Parra-Membrives20,21, Peter D Siersema22, George F Black23, Stavros A Antoniou24,25.   

Abstract

BACKGROUND: Choledocholithiasis presents in a considerable proportion of patients with gallbladder disease. There are several management options, including preoperative or intraoperative endoscopic cholangiopancreatography (ERCP), and laparoscopic common bile duct exploration (LCBDE).
OBJECTIVE: To develop evidence-informed, interdisciplinary, European recommendations on the management of common bile duct stones in the context of intact gallbladder with a clinical decision to intervene to both the gallbladder and the common bile duct stones.
METHODS: We updated a systematic review and network meta-analysis of LCBDE, preoperative, intraoperative, and postoperative ERCP. We formed evidence summaries using the GRADE and the CINeMA methodology, and a panel of general surgeons, gastroenterologists, and a patient representative contributed to the development of a GRADE evidence-to-decision framework to select among multiple interventions.
RESULTS: The panel reached unanimous consensus on the first Delphi round. We suggest LCBDE over preoperative, intraoperative, or postoperative ERCP, when surgical experience and expertise are available; intraoperative ERCP over LCBDE, preoperative or postoperative ERCP, when this is logistically feasible in a given healthcare setting; and preoperative ERCP over LCBDE or postoperative ERCP, when intraoperative ERCP is not feasible and there is insufficient experience or expertise with LCBDE (weak recommendation). The evidence summaries and decision aids are available on the platform MAGICapp ( https://app.magicapp.org/#/guideline/nJ5zyL ).
CONCLUSION: We developed a rapid guideline on the management of common bile duct stones in line with latest methodological standards. It can be used by healthcare professionals and other stakeholders to inform clinical and policy decisions. GUIDELINE REGISTRATION NUMBER: IPGRP-2022CN170.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  AGREE-S; Choledocholithiasis; Common bile duct stones; ERCP; Guidelines; Laparoscopic common bile duct exploration

Year:  2022        PMID: 36229556     DOI: 10.1007/s00464-022-09662-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  43 in total

1.  A prospective study of common bile duct calculi in patients undergoing laparoscopic cholecystectomy: natural history of choledocholithiasis revisited.

Authors:  Chris Collins; Donal Maguire; Adrian Ireland; Edward Fitzgerald; Gerald C O'Sullivan
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

Review 2.  Epidemiology and natural history of common bile duct stones and prediction of disease.

Authors:  Cynthia W Ko; Sum P Lee
Journal:  Gastrointest Endosc       Date:  2002-12       Impact factor: 9.427

3.  Guidelines International Network: toward international standards for clinical practice guidelines.

Authors:  Amir Qaseem; Frode Forland; Fergus Macbeth; Günter Ollenschläger; Sue Phillips; Philip van der Wees
Journal:  Ann Intern Med       Date:  2012-04-03       Impact factor: 25.391

4.  GRADE guidelines: 2. Framing the question and deciding on important outcomes.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; David Atkins; Jan Brozek; Gunn Vist; Philip Alderson; Paul Glasziou; Yngve Falck-Ytter; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2010-12-30       Impact factor: 6.437

5.  Preoperative endoscopic sphincterotomy versus laparoendoscopic rendezvous in patients with gallbladder and bile duct stones.

Authors:  Mario Morino; Filippo Baracchi; Claudio Miglietta; Niccolò Furlan; Riccardo Ragona; Aldo Garbarini
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

6.  Development of the summary of findings table for network meta-analysis.

Authors:  Juan José Yepes-Nuñez; Shelly-Anne Li; Gordon Guyatt; Susan M Jack; Jan L Brozek; Joseph Beyene; M Hassan Murad; Bram Rochwerg; Lawrence Mbuagbaw; Yuan Zhang; Ivan D Flórez; Reed A Siemieniuk; Behnam Sadeghirad; Reem Mustafa; Nancy Santesso; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2019-05-02       Impact factor: 6.437

7.  Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis.

Authors:  Romina Brignardello-Petersen; Ashley Bonner; Paul E Alexander; Reed A Siemieniuk; Toshi A Furukawa; Bram Rochwerg; Glen S Hazlewood; Waleed Alhazzani; Reem A Mustafa; M Hassan Murad; Milo A Puhan; Holger J Schünemann; Gordon H Guyatt
Journal:  J Clin Epidemiol       Date:  2017-10-17       Impact factor: 6.437

8.  Nationwide Assessment of Trends in Choledocholithiasis Management in the United States From 1998 to 2013.

Authors:  Michael W Wandling; Eric S Hungness; Emily S Pavey; Jonah J Stulberg; Ben Schwab; Anthony D Yang; Michael B Shapiro; Karl Y Bilimoria; Clifford Y Ko; Avery B Nathens
Journal:  JAMA Surg       Date:  2016-12-01       Impact factor: 14.766

9.  Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews.

Authors:  Chantelle Garritty; Gerald Gartlehner; Barbara Nussbaumer-Streit; Valerie J King; Candyce Hamel; Chris Kamel; Lisa Affengruber; Adrienne Stevens
Journal:  J Clin Epidemiol       Date:  2020-10-15       Impact factor: 6.437

10.  CINeMA: An approach for assessing confidence in the results of a network meta-analysis.

Authors:  Adriani Nikolakopoulou; Julian P T Higgins; Theodoros Papakonstantinou; Anna Chaimani; Cinzia Del Giovane; Matthias Egger; Georgia Salanti
Journal:  PLoS Med       Date:  2020-04-03       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.